To view a complete list of BC publications and related tools, please click here. Publications and related tools are organized in a Google spreadsheet that is sortable and filterable by each column. Direct clickable links to publication DOIs are provided.
Tools related to the BC case definition publications are designed to facilitate determining level of diagnostic certainty. Tools may include data abstraction forms, tabular checklists, decision tree algorithms to translate the collected data into a level of diagnostic certainty, and in the future, ICD/MedDRA coding.
New BC news, webinars, publications and related tools relevant for COVID-19 will be posted below and added to the spreadsheet as they become available. To view all Brighton Collaboration (BC) news posts, please click here. To view all BC webinar posts, please click here. For translations of BC publications and related tools to languages other than English, please click here.
This is a Brighton Collaboration case definition of the term “Vaccine-associated Enhanced Disease” (VAED) to be utilized in the evaluation of adverse events following immunization. The case definition was developed…
To find updated repositories of publications and safety profiles from COVID-19 vaccine clinical trials, please visit one or both of the following external sites: The COVID-19 vaccine tracker from the…
Vaccine monitoring Collaboration for Europe (VAC4EU) and the Brighton Collaboration's Safety Platform for Emergency vACcines (SPEAC) project jointly held a scientific webinar on how to assess Vaccine Mediated Enhanced Disease…
Brighton Collaboration's Webinar on Tools for COVID-19 Vaccine Safety Assessment was held on Thursday, August 27th at 11 AM - 12:30 PM EDT | 5 PM - 6:30 PM CEST.For…
Several inactivated viral vaccine candidates are among the COVID-19 vaccines in development. The Brighton Collaboration (BC) Benefit-Risk Assessment of VAccines by TechnolOgy (BRAVATO), as part of the Safety Platform for Emergency…
The Coalition for Epidemic Preparedness Innovation (CEPI) has partnered with the Brighton Collaboration to support the safety assessment of its candidate vaccines, including SARS-COV-2. Four AESI have been targeted for case…
Several protein vaccine candidates are among the COVID-19 vaccines in development. The Brighton Collaboration's Benefit-Risk Assessment of VAccines by TechnolOgy (BRAVATO), as part of the Safety Platform for Emergency vACcines (SPEAC)…
The COVID-19 pandemic has devastated the world as we know it. Nucleic acid (DNA and RNA) vaccines are among the most advanced vaccines for COVID-19 under development. These vaccine technology…
The Coalition for Epidemic Preparedness Innovations (CEPI) has contracted with the Brighton Collaboration, through the Task Force for Global Health (TFGH), to harmonize the safety assessment of CEPI-funded vaccines via…
Since the emergence of a new coronavirus, SARS-CoV-2, in China, there has been an unprecedented need to quickly develop an effective vaccine in light of the pandemic that was declared…